Back to Search
KENNY BAILEY, RPH
RPH
Pharmacist
NPI: 1619574183Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
24104(TX)
Clinical Trials (1)
1
Linked Trials
0
Recruiting
1
With Results
Research & Publications (7)
Safety and Efficacy of CYP2C19 Genotype-Guided Escalation of P2YInhibitor Therapy After Percutaneous Coronary Intervention in Chronic Kidney Disease: a Post Hoc Analysis of the TAILOR-PCI Study.
PMID 36445624·Cardiovasc Drugs Ther·2024
2-rct
Genetic-Guided Oral P2YInhibitor Selection and Cumulative Ischemic Events After Percutaneous Coronary Intervention.
PMID 37045502·JACC Cardiovasc Interv·2023
2-rct
Point of care CYP2C19 genotyping after percutaneous coronary intervention.
PMID 35449399·Pharmacogenomics J·2022
6-review
ABCD-GENE Score and Clinical Outcomes Following Percutaneous Coronary Intervention: Insights from the TAILOR-PCI Trial.
PMID 35132875·J Am Heart Assoc·2022
3-trial
Sex-Specific Differences in Clinical Outcomes After Percutaneous Coronary Intervention: Insights from the TAILOR-PCI Trial.
PMID 35699175·J Am Heart Assoc·2022
2-rct
Patient Onboarding and Engagement to Build a Digital Study After Enrollment in a Clinical Trial (TAILOR-PCI Digital Study): Intervention Study.
PMID 35699977·JMIR Form Res·2022
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 155 W MONROE ST
KOUNTZE, TX 77625 - Phone
- (409) 246-2525
Quick Facts
- NPI
- 1619574183
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 1
- Publications
- 7
Are you this provider?
Claim Your Profile